PTGDS and COVID-19: Notably, the downregulation/knock-out of PTGDS is known to increase vascular permeability, neutrophilic influx and lung damage, in line with the clinical presentation of severe COVID-19 (78), which might be counteracted by COX2 inhibition (79).